Print

Cerbomed Opens Up New Markets: From March on t-VNS With NEMOS Will be Available in Italy for the Treatment of Epilepsies  
2/21/2013 9:21:26 AM

ERLANGEN, Germany--(BUSINESS WIRE)--More than 500,000 patients suffer from epilepsy in Italy. Not all of them can be treated sufficiently with available anticonvulsive medication. Therefore the medical device company cerbomed GmbH from Erlangen, Germany, announces that, from March 2013 on, transcutaneous vagus nerve stimulation (t-VNS) with NEMOS will be available to Italian epilepsy patients. To address the Italian market, cerbomed is cooperating with MARVAMED, a medical devices sales specialist experienced in the Italian neurology market. This is the first, successful step in extending into new European markets. Cooperations with further European distributors should follow in the course of the year.
//-->